ArticleJournal of ultrasound2025
Decade-long landscape of transrectal ultrasound (TRUS) in prostate cancer research: trends, collaborations, and emerging frontiers.
Article in Journal of ultrasound, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diagnosis of Prostate Cancer: A Comparative Evaluation of Biological Techniques.Diseases (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo systematically reveal the spatiotemporal distribution, collaboration networks, and thematic evolution of global transrectal ultrasound (TRUS) research in prostate cancer from 2015 to 2024 using bibliometric analysis and visualization.
methodsA total of 12,894 relevant articles from the Web of Science database were analyzed using VOSviewer and CiteSpace for co-occurrence networks, burst detection, and density visualization, combined with social network analysis (SNA) and kernel density estimation (KDE) to decode country/institution collaboration patterns and geographical agglomeration.
resultsAnnual publications peaked at 1800 in 2019, with a secondary surge in 2023 (1563 articles) driven by AI applications (e.g., AI-assisted biopsy). Mean citations per article reached 7.8 in 2020, coinciding with the release of GLOBOCAN 2020 and the rise of teleultrasound research. The United States (5333 articles) and Canada formed the North American core cluster (edge weight 5333 × 1099), while the UK (1287 articles) and Germany served as secondary hubs in Europe. Asian countries showed scattered distributions, though South Korea (2015-2017 burst strength 7.64, elastography) and Australia (2019-2022 burst strength 8.33, focal ablation) emerged as regional technical frontiers. The University of Toronto (242 articles) led TRUS-targeted biopsy research, while the University of Michigan became a rising affiliation due to TRUS-AI integration (post-2020 annual publications > 50). The high-impact journal J Clin Oncol (5783 citations) focused on fusion biopsy, with annual articles increasing from 42 to 117.Keywords shifted from "systematic biopsy" (2015-2017) and "radiotherapy planning" (2018-2020) to "AI-assisted diagnosis" (2021-2024 burst strength 20.6) and "teleultrasound" (COVID-19-related studies, annual growth 19%), reflecting technology-driven clinical transformation.
conclusionTRUS research exhibits significant regional inequality and technological iteration, with AI integration and multimodal fusion (e.g., MRI-TRUS fusion) as future priorities. Strengthening cross-regional collaboration is recommended to promote technological equity, particularly for low-cost TRUS innovations in resource-constrained regions.
Indexed as
Identifiers
41205113What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.